Want to see JP:3087 full AI Analyst Report?
Top Page
Doutor Nichires Holdings Co., Ltd.
(3087)
Select Model
Select Model
Rating:76Outperform
Price Target:
¥3,853.00
▲(12.99% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by solid fundamentals—especially an exceptionally low-leverage balance sheet and improving profitability—tempered by uneven cash-flow conversion. Technicals add support with a positive trend and neutral momentum readings, while valuation is fair (P/E ~17) with a modest dividend yield (~1.78%).
Positive Factors
Very Low Financial Leverage
Minimal leverage reduces financial risk, interest burden and refinancing dependence. It also gives Doutor Nichires flexibility to sustain operations, invest in stores or support franchise growth through changing economic conditions.
Negative Factors
Inconsistent Cash-Flow Conversion
Uneven operating cash flow and weak conversion of earnings into free cash flow may reflect working-capital pressure or higher reinvestment needs. If persistent, this could constrain internally funded expansion and reduce the quality of reported profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Financial Leverage
Minimal leverage reduces financial risk, interest burden and refinancing dependence. It also gives Doutor Nichires flexibility to sustain operations, invest in stores or support franchise growth through changing economic conditions.
Read all positive factors
Doutor Nichires Holdings Co., Ltd. (3087) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥148.57B
Dividend Yield1.83%
Average Volume (3M)135.27K
Price to Earnings (P/E)17.9
Beta (1Y)0.33
Revenue Growth7.36%
EPS Growth24.66%
CountryJP
Employees2,892
SectorConsumer Cyclical
Sector Strength84
IndustryRestaurants
Share Statistics
EPS (TTM)170.69
Shares Outstanding45,609,760
10 Day Avg. Volume110,280
30 Day Avg. Volume135,273
Financial Highlights & Ratios
PEG Ratio2.00
Price to Book (P/B)1.21
Price to Sales (P/S)0.80
P/FCF Ratio65.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)185.62
Revenue Forecast (FY)¥169.60B
Doutor Nichires Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
DOUTOR NICHIRES Holdings Co., Ltd., together with its subsidiaries, operates and manages coffee shops and restaurants in Japan. It manufactures and sells breads and pastries; roasts, processes and sells coffee; and imports, exports, purchases, and...
How the Company Makes Money
The company makes money primarily through its food-service operations. Key revenue streams typically include (1) sales from company-operated stores, where revenue is generated directly from in-store customer purchases of beverages and food; and (2...
Doutor Nichires Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
62
Positive
| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 159.15B | 148.82B | 140.63B | 126.86B | 109.36B |
| Gross Profit | 93.69B | 89.62B | 84.19B | 74.77B | 64.31B |
| EBITDA | 14.82B | 14.20B | 11.58B | 6.88B | 2.40B |
| Net Income | 7.23B | 6.88B | 5.49B | 3.43B | 1.22B |
Balance Sheet | |||||
| Total Assets | 136.52B | 134.23B | 127.79B | 121.04B | 118.23B |
| Cash, Cash Equivalents and Short-Term Investments | 29.42B | 38.99B | 35.80B | 32.22B | 34.55B |
| Total Debt | 2.08B | 2.11B | 2.77B | 2.03B | 1.54B |
| Total Liabilities | 30.96B | 29.88B | 28.31B | 24.74B | 24.11B |
| Stockholders Equity | 105.18B | 104.00B | 99.16B | 96.02B | 93.86B |
Cash Flow | |||||
| Free Cash Flow | 1.93B | 6.49B | 7.33B | 142.00M | 10.43B |
| Operating Cash Flow | 7.02B | 12.35B | 11.79B | 5.17B | 14.64B |
| Investing Cash Flow | -10.81B | -6.23B | -4.90B | -5.59B | -4.93B |
| Financing Cash Flow | -8.42B | -2.93B | -3.37B | -1.98B | -1.50B |
Doutor Nichires Holdings Co., Ltd. Technical Analysis
Neutral
3410.00
Price Trends
3069.81
Positive
2891.66
Positive
2806.46
Positive
Market Momentum
84.40
Positive
54.37
Neutral
25.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3087, the sentiment is Neutral. The current price of 3410 is above the 20-day moving average (MA) of 3280.55, above the 50-day MA of 3069.81, and above the 200-day MA of 2806.46, indicating a neutral trend. The MACD of 84.40 indicates Positive momentum. The RSI at 54.37 is Neutral, neither overbought nor oversold. The STOCH value of 25.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3087.
Doutor Nichires Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥148.57B | 17.90 | ― | 1.83% | 7.36% | 24.66% | |
73 Outperform | ¥349.43B | 29.10 | 9.75% | 0.48% | 16.06% | 12.26% | |
70 Outperform | ¥132.16B | 22.70 | 10.80% | 1.32% | 6.72% | 18.77% | |
68 Neutral | ¥134.21B | 19.75 | ― | 2.14% | 18.68% | 13.05% | |
68 Neutral | ¥120.41B | 30.84 | ― | 0.88% | 6.32% | 10.13% | |
63 Neutral | ¥769.87B | 40.41 | 10.08% | 0.72% | 11.29% | 22.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
* Consumer Cyclical Sector Average
JP:3087
Doutor Nichires Holdings Co., Ltd.
3,280.00
682.58
26.28%
JP:8179
Royal Holdings Co
1,325.00
-25.93
-1.92%
JP:3197
Skylark Holdings Co
3,317.00
240.46
7.82%
JP:7581
Saizeriya Co
7,270.00
2,035.50
38.89%
JP:3543
KOMEDA Holdings Co., Ltd.
2,853.00
-129.49
-4.34%
JP:8153
MOS FOOD SERVICES, INC.
3,865.00
-116.50
-2.93%
Doutor Nichires Holdings Co., Ltd. Corporate Events
Doutor Nichires Lifts Quarterly Profit Over 30%, Keeps Full-Year Outlook Intact
Jul 13, 2026
Doutor Nichires Holdings reported solid growth for the three months ended May 31, 2026, with net sales rising 8.2% year on year to ¥42.53 billion and profit attributable to owners of parent climbing 31.4% to ¥2.72 billion. Operating and ...
Doutor Nichires Completes Treasury Share Disposal for Restricted Stock Compensation
Jun 26, 2026
Doutor Nichires Holdings has completed the payment procedures for the disposal of 52,100 treasury shares under its restricted stock compensation plan approved by the board on May 27, 2026. The shares, priced at ¥2,663 each for a total of abou...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.